Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Hematology and Cell Therapy
Published in: Hematology and Cell Therapy 1/1997

01-02-1997 | Original article

Modulation of human and mouse erythropoiesis by thyroid hormone and retinoic acid: evidence for specific effects at different steps of the erythroid pathway

Authors: M. C. Perrin, J. P. Blanchet, G. Mouchiroud

Published in: Hematology and Cell Therapy | Issue 1/1997

Login to get access
Metadata
Title
Modulation of human and mouse erythropoiesis by thyroid hormone and retinoic acid: evidence for specific effects at different steps of the erythroid pathway
Authors
M. C. Perrin
J. P. Blanchet
G. Mouchiroud
Publication date
01-02-1997
Publisher
Springer-Verlag
Published in
Hematology and Cell Therapy / Issue 1/1997
Print ISSN: 1269-3286
Electronic ISSN: 1279-8509
DOI
https://doi.org/10.1007/s00282-997-0019-2

Other articles of this Issue 1/1997

Hematology and Cell Therapy 1/1997 Go to the issue

Original article

Peripheral blood stem cell CD34+ autologous transplant in relapsed follicular lymphoma

Original article

Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukaemic transformation and review of the literature

Original article

Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias

Original article

Presenting features at diagnosis and complications of hemophilia in Dakar: apropos of 25 cases

Original article

Plasma cytokines in graft vs host disease and complications following bone marrow transplantation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits